By using the neutralizing antibodies to IL-17A or IL-17R, we hypothesized that blockade of the IL-17A/IL-17R pathway on microglial cells could suppress the potent cerebral inflammatory response, thereby preventing the cognitive impairment during sepsis. The gene discussed is IL17A; the disease is Sepsis.